Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

July 24, 2023

Study Completion Date

August 10, 2023

Conditions
Birth Asphyxia
Interventions
DRUG

Magnesium sulfate

"All babies with moderate or severe Hypoxic Ischemic Encephalopathy fulfilling the inclusion criteria will be randomized to receive either the standard treatment (oxygen and fluid therapy along with anticonvulsants if required) plus 3.0 ml/kg of 10% dextrose water given over 30 minutes, three dose given 24 hours apart or to receive standard treatment PLUS three doses of Magnesium Sulphate infusion given over 30 minutes at 250 mg/kg per dose given 24 hours apart. The volume of infusion shall be adjusted with 10% dextrose water to make it~up to 3.0 ml. The resulting reconstituted solution for intravenous infusion shall be 8.3% Magnesium Sulphate delivered over 30 minutes at a rate of 0.1 ml/kg/minute i.e. 8.3 mg/kg/minute. The treatment should be started as soon after birth as possible and not later than 24 hours of life. The babies who meet the exclusion criteria will not be continued into the study."

Trial Locations (1)

54610

services hospital Pakistan, Lahore

All Listed Sponsors
lead

University of Health Sciences Lahore

OTHER